MRCP2-2625

MRCP2-2625

A 28-year-old man presents to his first HIV clinic appointment. He has routine three month HIV tests. He received contact tracing notification last week and was tested and found to be HIV positive. He has just started antiretroviral treatment.

During the appointment, he expresses concern about his upcoming travel plans to South America and whether his new HIV diagnosis will affect his ability to receive necessary vaccinations. He understands that he is currently immunosuppressed and at risk of infections, but is committed to taking his medication as prescribed.

The following are his laboratory results:
– Hemoglobin: 115 g/L (130-180)
– White blood cell count: 6.8 10^9/L (4.0-11.0)
– Neutrophil count: 5.2 10^9/L (1.5-7.0)
– Platelet count: 175 10^9/L (150-400)
– CD4 count: 200 cells/mm3 (600-1500)

Which of the travel vaccinations is safe for him to receive?